Heme Oxygenase-1-derived Bilirubin Counteracts HIV Protease Inhibitor-mediated Endothelial Cell Dysfunction

Overview

Journal Free Radic Biol Med

Specialties Biochemistry
Biology
General Medicine

Date 2016 Mar 13

PMID 26968795

Citations 17

Authors

Xiao-Ming Liu

Zane E Durante

Kelly J Peyton

William Durante

Affiliations

Soon will be listed here.

Abstract

The use of HIV protease inhibitors (PIs) has extended the duration and quality of life for HIV-positive individuals. However there is increasing concern that this antiviral therapy may promote premature cardiovascular disease by impairing endothelial cell (EC) function. In the present study, we investigated the effect of HIV PIs on EC function and determined if the enzyme heme oxygenase (HO-1) influences the biological action of these drugs. We found that three distinct PIs, including ritonavir, atazanavir, and lopinavir, stimulated the expression of HO-1 protein and mRNA. The induction of HO-1 was associated with an increase in NF-E2-related factor-2 (Nrf2) activity and reactive oxygen species (ROS). PIs also stimulated HO-1 promoter activity and this was prevented by mutating the antioxidant responsive element or by overexpressing dominant-negative Nrf2. In addition, the PI-mediated induction of HO-1 was abolished by N-acetyl-l-cysteine and rotenone. Furthermore, PIs blocked EC proliferation and migration and stimulated the expression of intercellular adhesion molecule-1 and the adhesion of monocytes on ECs. Inhibition of HO-1 activity or expression potentiated the anti-proliferative and inflammatory actions of PIs which was reversed by bilirubin but not carbon monoxide. Alternatively, adenovirus-mediated overexpression of HO-1 attenuated the growth-inhibitory and inflammatory effect of PIs. In contrast, blocking HO-1 activity failed to modify the anti-migratory effect of the PIs. Thus, induction of HO-1 via the ROS-Nrf2 pathway in human ECs counteracts the anti-proliferative and inflammatory actions of PIs by generating bilirubin. Therapeutic approaches targeting HO-1 may provide a novel approach in preventing EC dysfunction and vascular disease in HIV-infected patients undergoing antiretroviral therapy.

Citing Articles

Heme catabolism and heme oxygenase-1-expressing myeloid cells in pathophysiology.

Consonni F, Incerti M, Bertolotti M, Ballerini G, Garlatti V, Sica A Front Immunol. 2024; 15:1433113.

PMID: 39611159 PMC: 11604077. DOI: 10.3389/fimmu.2024.1433113.

HIV Infection, Antiretroviral Drugs, and the Vascular Endothelium.

Kanmogne G Cells. 2024; 13(8.

PMID: 38667287 PMC: 11048826. DOI: 10.3390/cells13080672.

Heme oxygenase-1 is an equid alphaherpesvirus 8 replication restriction host protein and suppresses viral replication via the PKCβ/ERK1/ERK2 and NO/cGMP/PKG pathway.

Wang T, Li S, Hu X, Geng Y, Chen L, Liu W Microbiol Spectr. 2024; 12(4):e0322023.

PMID: 38441979 PMC: 10986571. DOI: 10.1128/spectrum.03220-23.

Cobalt Protoporphyrin Blocks EqHV-8 Infection via IFN-α/β Production.

Li L, Hu X, Li S, Li Y, Zhao S, Shen F Animals (Basel). 2023; 13(17).

PMID: 37684954 PMC: 10487175. DOI: 10.3390/ani13172690.

Glutamine Deficiency Promotes Immune and Endothelial Cell Dysfunction in COVID-19.

Durante W Int J Mol Sci. 2023; 24(8).

PMID: 37108759 PMC: 10144995. DOI: 10.3390/ijms24087593.

References

Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T . Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol. 2004; 25(1):155-60. DOI: 10.1161/01.ATV.0000148405.18071.6a. View

Chen C, Lu X, Yan S, Chai H, Yao Q . HIV protease inhibitor ritonavir increases endothelial monolayer permeability. Biochem Biophys Res Commun. 2005; 335(3):874-82. DOI: 10.1016/j.bbrc.2005.07.155. View

Gary-Bobo G, Houssaini A, Amsellem V, Rideau D, Pacaud P, Perrin A . Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats. Circulation. 2010; 122(19):1937-47. PMC: 3151528. DOI: 10.1161/CIRCULATIONAHA.110.973750. View

Soares M, Seldon M, Gregoire I, Vassilevskaia T, Berberat P, Yu J . Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol. 2004; 172(6):3553-63. DOI: 10.4049/jimmunol.172.6.3553. View

Zhong D, Lu X, Conklin B, Lin P, Lumsden A, Yao Q . HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells. Arterioscler Thromb Vasc Biol. 2002; 22(10):1560-6. DOI: 10.1161/01.atv.0000034707.40046.02. View

Taburet A, Raguin G, Le Tiec C, Droz C, Barrail A, Vincent I . Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus. Clin Pharmacol Ther. 2004; 75(4):310-23. DOI: 10.1016/j.clpt.2003.12.013. View

Conklin B, Fu W, Lin P, Lumsden A, Yao Q, Chen C . HIV protease inhibitor ritonavir decreases endothelium-dependent vasorelaxation and increases superoxide in porcine arteries. Cardiovasc Res. 2004; 63(1):168-75. DOI: 10.1016/j.cardiores.2004.03.020. View

de Saint Martin L, Vandhuick O, Guillo P, Bellein V, Bressollette L, Roudaut N . Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study). Atherosclerosis. 2005; 185(2):361-7. DOI: 10.1016/j.atherosclerosis.2005.06.049. View

Chi P, Lin C, Chen Y, Hsiao L, Yang C . CO Induces Nrf2-Dependent Heme Oxygenase-1 Transcription by Cooperating with Sp1 and c-Jun in Rat Brain Astrocytes. Mol Neurobiol. 2014; 52(1):277-92. DOI: 10.1007/s12035-014-8869-4. View

10.

Friis-Moller N, Reiss P, Sabin C, Weber R, Monforte A, El-Sadr W . Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007; 356(17):1723-35. DOI: 10.1056/NEJMoa062744. View

11.

Pyrko P, Kardosh A, Wang W, Xiong W, Schonthal A, Chen T . HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress. Cancer Res. 2007; 67(22):10920-8. DOI: 10.1158/0008-5472.CAN-07-0796. View

12.

Mondal D, Pradhan L, Ali M, Agrawal K . HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells: exacerbation by inflammatory cytokines and amelioration by antioxidants. Cardiovasc Toxicol. 2004; 4(3):287-302. DOI: 10.1385/ct:4:3:287. View

13.

Wang X, Chai H, Lin P, Yao Q, Chen C . Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells. Am J Pathol. 2009; 174(3):771-81. PMC: 2665739. DOI: 10.2353/ajpath.2009.080157. View

14.

Lefevre C, Auclair M, Boccara F, Bastard J, Capeau J, Vigouroux C . Premature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statin. Arterioscler Thromb Vasc Biol. 2010; 30(12):2611-20. DOI: 10.1161/ATVBAHA.110.213603. View

15.

Chai H, Yang H, Yan S, Li M, Lin P, Lumsden A . Effects of 5 HIV protease inhibitors on vasomotor function and superoxide anion production in porcine coronary arteries. J Acquir Immune Defic Syndr. 2005; 40(1):12-9. DOI: 10.1097/01.qai.0000172368.05327.7b. View

16.

Auclair M, Afonso P, Capel E, Caron-Debarle M, Capeau J . Impact of darunavir, atazanavir and lopinavir boosted with ritonavir on cultured human endothelial cells: beneficial effect of pravastatin. Antivir Ther. 2014; 19(8):773-82. DOI: 10.3851/IMP2752. View

17.

Durante W . Targeting heme oxygenase-1 in vascular disease. Curr Drug Targets. 2010; 11(12):1504-16. PMC: 2978667. DOI: 10.2174/1389450111009011504. View

18.

Klein D, Hurley L, Quesenberry Jr C, Sidney S . Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?. J Acquir Immune Defic Syndr. 2002; 30(5):471-7. DOI: 10.1097/00126334-200208150-00002. View

19.

Durante W, Peyton K, Schafer A . Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999; 19(11):2666-72. DOI: 10.1161/01.atv.19.11.2666. View

20.

Liu X, Peyton K, Shebib A, Wang H, Durante W . Compound C stimulates heme oxygenase-1 gene expression via the Nrf2-ARE pathway to preserve human endothelial cell survival. Biochem Pharmacol. 2011; 82(4):371-9. PMC: 3138903. DOI: 10.1016/j.bcp.2011.05.016. View